European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 0.59% to 1,890.80 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and accommodations booking company trivago (TRVG), which increased 0.8% and 0.3% respectively. They were followed by lender Banco Santander (SAN) and medical device maker EDAP TMS (FOCL), which advanced 0.9% and 1.1% respectively.
The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and oil and gas company Eni (E), which dropped 2% and 2.3% respectively. They were followed by petroleum refiner Equinor (EQNR) and healthcare tech company Philips (PHG), which lost 2% and 1.5% respectively.
The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and tobacco company British American Tobacco (BTI), which rose 7.7% and 0.8% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which were up 2.6% and 0.1%, respectively.
The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and oil and gas company Shell (SHEL), which fell 5.1% and 2%, respectively. They were followed by pharmaceutical company medica device maker Smith & Nephew (SNN), which was down 1.3%.
Comments